The latest price target for Coya Therapeutics (NASDAQ: COYA) was reported by Chardan Capital on January 26, 2023. The analyst firm set a price target for $9.00 expecting COYA to rise to within 12 months (a possible 88.28% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Coya Therapeutics (NASDAQ: COYA) was provided by Chardan Capital, and Coya Therapeutics initiated their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on January 26, 2023 so you should expect the next rating to be made available sometime around January 26, 2024.

While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a initiated with a price target of $0.00 to $9.00. The current price Coya Therapeutics (COYA) is trading at is $4.78, which is within the analyst's predicted range.